Importance of Engaging a Safety Partner Early in the Drug Life Cycle

Ms. Jeanne Schow, Vice President & US Head of Business Development talks the key benefits of onboarding a Safety Partner early on in the drug life cycle; key considerations for onboarding a Safety Partner; and how early onboarding enables better strategic decision making for the Post-Marketing phase.